Average Co-Inventor Count = 4.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rigel Pharmaceuticals, Incorporated (16 from 488 patents)
2. Onyx Therapeutics, Inc. (14 from 50 patents)
3. Calithera Biosciences, Inc. (3 from 30 patents)
4. Other (1 from 832,680 patents)
5. Proteolix, Inc. (1 from 5 patents)
35 patents:
1. 10940148 - Combination therapy with glutaminase inhibitors and immuno-oncology agents
2. RE47954 - Combination therapy with peptide epoxyketones
3. 10596222 - Combination therapy with peptide epoxyketones
4. 10258619 - Combination therapy with glutaminase inhibitors and immuno-oncology agents
5. 10195197 - Combination therapy with glutaminase inhibitors
6. 9657058 - Compounds for enzyme inhibition
7. 9511109 - Combination therapy with peptide epoxyketones
8. 9359398 - Compounds for immunoproteasome inhibition
9. 9040462 - In vivo production of cyclic peptides for inhibiting protein-protein interaction
10. 8895034 - Collagen production compound
11. 8765745 - Compounds for enzyme inhibition
12. 8735441 - Compounds for enzyme inhibition
13. 8697837 - Substrate for Rpn 11 enzymatic activity
14. 8609654 - Compounds for enzyme inhibition
15. 8431571 - Compounds for enzyme inhibition